SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008786
Filing Date
2018-11-07
Accepted
2018-11-07 16:04:26
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20180930x10q.htm 10-Q 1832556
2 EX-31.1 ardx-20180930ex3116ab7f0.htm EX-31.1 22337
3 EX-31.2 ardx-20180930ex31235c409.htm EX-31.2 22321
4 EX-32.1 ardx-20180930ex3211eec1e.htm EX-32.1 16840
  Complete submission text file 0001558370-18-008786.txt   6436346

Data Files

Seq Description Document Type Size
5 EX-101.INS ardx-20180930.xml EX-101.INS 1497218
6 EX-101.SCH ardx-20180930.xsd EX-101.SCH 39056
7 EX-101.CAL ardx-20180930_cal.xml EX-101.CAL 48334
8 EX-101.DEF ardx-20180930_def.xml EX-101.DEF 136803
9 EX-101.LAB ardx-20180930_lab.xml EX-101.LAB 295913
10 EX-101.PRE ardx-20180930_pre.xml EX-101.PRE 250631
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 181166240
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1